BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32088220)

  • 21. Low nanomolar concentrations of Cucurbitacin-I induces G2/M phase arrest and apoptosis by perturbing redox homeostasis in gastric cancer cells in vitro and in vivo.
    Deng C; Zhang B; Zhang S; Duan C; Cao Y; Kang W; Yan H; Ding X; Zhou F; Wu L; Duan G; Shen S; Xu G; Zhang W; Chen M; Huang S; Zhang X; Lv Y; Ling T; Wang L; Zou X
    Cell Death Dis; 2016 Feb; 7(2):e2106. PubMed ID: 26890145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.
    Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG
    World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cucurbitacin B synergistically enhances the apoptosis-inducing effect of arsenic trioxide by inhibiting STAT3 phosphorylation in lymphoma Ramos cells.
    Ding X; Chi J; Yang X; Hao J; Liu C; Zhu C; Wang X; Liu X; Niu Y; Ji W; Chen D; Wu X
    Leuk Lymphoma; 2017 Oct; 58(10):2439-2451. PubMed ID: 28278714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and biological evaluation of novel potent STAT3 inhibitors based on BBI608 for cancer therapy.
    Feng KR; Wang F; Shi XW; Tan YX; Zhao JY; Zhang JW; Li QH; Lin GQ; Gao D; Tian P
    Eur J Med Chem; 2020 Sep; 201():112428. PubMed ID: 32603980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells.
    Lui VW; Yau DM; Wong EY; Ng YK; Lau CP; Ho Y; Chan JP; Hong B; Ho K; Cheung CS; Tsang CM; Tsao SW; Chan AT
    Carcinogenesis; 2009 Dec; 30(12):2085-94. PubMed ID: 19843642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer.
    Canesin G; Evans-Axelsson S; Hellsten R; Sterner O; Krzyzanowska A; Andersson T; Bjartell A
    Eur Urol; 2016 Mar; 69(3):400-4. PubMed ID: 26144873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cucurbitacin B Induces the Lysosomal Degradation of EGFR and Suppresses the CIP2A/PP2A/Akt Signaling Axis in Gefitinib-Resistant Non-Small Cell Lung Cancer.
    Liu P; Xiang Y; Liu X; Zhang T; Yang R; Chen S; Xu L; Yu Q; Zhao H; Zhang L; Liu Y; Si Y
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30759826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cucurbitacin B inhibits growth and induces apoptosis through the JAK2/STAT3 and MAPK pathways in SH‑SY5Y human neuroblastoma cells.
    Zheng Q; Liu Y; Liu W; Ma F; Zhou Y; Chen M; Chang J; Wang Y; Yang G; He G
    Mol Med Rep; 2014 Jul; 10(1):89-94. PubMed ID: 24789581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Luteolin selectively kills STAT3 highly activated gastric cancer cells through enhancing the binding of STAT3 to SHP-1.
    Song S; Su Z; Xu H; Niu M; Chen X; Min H; Zhang B; Sun G; Xie S; Wang H; Gao Q
    Cell Death Dis; 2017 Feb; 8(2):e2612. PubMed ID: 28182003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of cucurbitacin B on cell proliferation and apoptosis in Hep-2 cells].
    Liu T; Zhang M; Deng Y; Zhang H; Sun C; Yang X; Ji W
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 May; 22(9):403-7. PubMed ID: 18652313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inactivation of ATP citrate lyase by Cucurbitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth.
    Gao Y; Islam MS; Tian J; Lui VW; Xiao D
    Cancer Lett; 2014 Jul; 349(1):15-25. PubMed ID: 24690568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of pancreatic cancer cell growth by cucurbitacin B through modulation of signal transducer and activator of transcription 3 signaling.
    Zhang M; Sun C; Shan X; Yang X; Li-Ling J; Deng Y
    Pancreas; 2010 Aug; 39(6):923-9. PubMed ID: 20182390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of ferroptosis in human nasopharyngeal cancer cells by cucurbitacin B: molecular mechanism and therapeutic potential.
    Huang S; Cao B; Zhang J; Feng Y; Wang L; Chen X; Su H; Liao S; Liu J; Yan J; Liang B
    Cell Death Dis; 2021 Mar; 12(3):237. PubMed ID: 33664249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted constitutive activation of signal transducer and activator of transcription 3 in human hepatocellular carcinoma cells by cucurbitacin B.
    Zhang M; Zhang H; Sun C; Shan X; Yang X; Li-Ling J; Deng Y
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):635-42. PubMed ID: 18521604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration.
    Chan KT; Meng FY; Li Q; Ho CY; Lam TS; To Y; Lee WH; Li M; Chu KH; Toh M
    Cancer Lett; 2010 Aug; 294(1):118-24. PubMed ID: 20153103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro.
    Tang YJ; Sun ZL; Wu WG; Xing J; He YF; Xin DM; Han P
    Genet Mol Res; 2015 Mar; 14(1):2450-60. PubMed ID: 25867391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.
    Tseng LM; Huang PI; Chen YR; Chen YC; Chou YC; Chen YW; Chang YL; Hsu HS; Lan YT; Chen KH; Chi CW; Chiou SH; Yang DM; Lee CH
    J Pharmacol Exp Ther; 2012 May; 341(2):410-23. PubMed ID: 22328572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy.
    Zhang W; Guo J; Li S; Ma T; Xu D; Han C; Liu F; Yu W; Kong L
    Sci Rep; 2017 Apr; 7():46352. PubMed ID: 28397855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
    Sun J; Blaskovich MA; Jove R; Livingston SK; Coppola D; Sebti SM
    Oncogene; 2005 May; 24(20):3236-45. PubMed ID: 15735720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.